EviCure

EviCure
Developing exosome-based cancer therapeutics using AI and novel human cancer models.
About
What does EviCure do?
EviCure Life Sciences is a startup focused on developing exosome-based therapeutics for cancer treatment. They leverage artificial intelligence, novel human cancer modeling, and controlled manufacturing capabilities to create these innovative treatments, with an initial focus on lung cancer.
Where is EviCure headquartered?
EviCure is headquartered in San Diego, United States.
When was EviCure founded?
EviCure was founded in 2023.
What industry does EviCure operate in?
EviCure operates in Life Sciences, Oncology, Lung, Biomarkers, Therapeutics, Biotech.
What is EviCure's current status?
EviCure's current operating status is: Inactive.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.